Why the study?
Significant racial and ethnic disparities exist in the incidence, recognition, referral, and outcomes of patients with dilated cardiomyopathy, influenced by social determinants including racism and bias.
There is an urgent need to prioritize a multifaceted social justice approach and address social determinants of health to eliminate racial and ethnic disparities in dilated cardiomyopathy.
Significant race- and ethnicity-based disparities among those diagnosed with dilated cardiomyopathy (DCM) exist and are deeply rooted in the history of many societies. The role of social determinants of racial disparities, including racism and bias, is often overlooked in cardiology. DCM incidence is higher in Black subjects; survival and other outcome measures are worse in Black patients with DCM, with fewer referrals for transplantation. DCM in Black patients is underrecognized and under-referred for effective therapies, a consequence of a complex interplay of social and socioeconomic factors. Strategies to manage social determinants of health must be multifaceted and consider changes in policy to expand access to equitable care; provision of insurance, education, and housing; and addressing racism and bias in health care workers. There is an urgent need to prioritize a social justice approach to health care and the pursuit of health equity to eliminate race and other disparities in the management of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Ntusi et al. (2021) conducted a review in Dilated cardiomyopathy. Racial and ethnic disparities was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: